Rapamycin started as a transplant drug, but today it’s being tested in cancer and longevity research. Here’s my take on how this molecule became a true medical revolution. From Soil Sample to Lifesaving Medicine Whenever I read about rapamycin’s history, I can’t help but be amazed. Imagine this: a compound discovered in the soil of…

Recent human studies suggest rapamycin may boost immunity, support brain health, and even influence women’s health. Could this be the first real step toward slowing human aging? A Shift from Mice to Humans For years, I’ve seen headlines about rapamycin extending lifespan in mice. That’s fascinating, of course—but the real question has always been: can…

Low-dose rapamycin shows promising results in ME/CFS patients, improving fatigue, stamina, and immune balance. Could this be a breakthrough treatment for chronic fatigue syndrome? ME/CFS: A Condition Still Waiting for Effective Treatments Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) affects millions worldwide, leaving patients with severe fatigue, cognitive impairment, and post-exertional malaise. Despite its impact, treatment options…

From Canada’s Discovery to Global Longevity Hype Could one tiny cellular pathway decide how fast we age? Discover how rapamycin and mTOR are reshaping the way we think about longevity and healthy aging. A Cellular “On/Off” Switch for Aging? I’ve always believed that aging isn’t just random—it feels more like a programmed process written into…

Rapamycin has long been studied as a potential longevity drug. But in 2025, the spotlight is shifting toward new and unexpected research directions—far beyond its classic role in slowing aging. Here are some of the most intriguing and lesser-known findings emerging this year: Rapamycin and Alzheimer’s: The First Human Data A recent phase I clinical…

Slowing aging is no longer just science fiction. A newly published scientific study shows that a combination of two FDA-approved drugs—rapamycin and trametinib—can significantly slow down aging and extend lifespan in mice. But here’s the most exciting part: it’s not just about living longer, it’s about living healthier. Two Different Pathways, One Shared Goal: A…

Rapamycin has gone from being a life-saving drug for transplant patients to one of the most intriguing candidates for slowing aging. But beyond the headlines, new research is uncovering surprising benefits that could change how we think about health and longevity. Rapamycin is more than just a transplant drug. From boosting muscle mass to delaying…

For generations, menopause has been a biological inevitability—a point of no return in a woman’s life that signals not only the end of fertility but also the start of increased health risks, from heart disease to osteoporosis. But what if menopause could be delayed? Not indefinitely, but just long enough to preserve health, well-being, and…

"How eating less (caloric restriction) and using Rapamycin might be related" "How both affect the same core biological pathway: the mTOR pathway" Both caloric restriction (CR) and rapamycin influence the mTOR pathway, a central regulator of growth, metabolism, and aging. mTOR stands for "mechanistic Target of Rapamycin" — the very molecule that rapamycin targets, and…

Breakthrough Drug Duo Prolongs Mouse Lifespan by 30% A pioneering study from Germany's Max Planck Institute for Biology of Aging has unveiled that a combination of two existing cancer medications—rapamycin and trametinib—can extend the lifespan of mice by approximately 30%. This discovery offers promising insights into potential anti-aging therapies for humans. The Study's Findings In…